X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
measuring (16) 16
measuring volume, volume flow, mass flow or liquidlevel (16) 16
metering by volume (16) 16
physics (16) 16
testing (16) 16
humans (14) 14
index medicus (14) 14
hypercholesterolemia (13) 13
cardiac & cardiovascular systems (12) 12
peripheral vascular disease (12) 12
risk factors (11) 11
familial hypercholesterolemia (10) 10
female (10) 10
male (10) 10
adult (8) 8
hyperlipoproteinemia type ii - genetics (8) 8
cardiovascular (7) 7
cholesterol (7) 7
middle aged (7) 7
care and treatment (6) 6
genetic aspects (6) 6
heterozygote (6) 6
low density lipoproteins (6) 6
mutation (6) 6
analysis (5) 5
cardiovascular diseases (5) 5
cholesterol, ldl - blood (5) 5
coronary heart disease (5) 5
diagnosis (5) 5
phenotype (5) 5
receptors, ldl - genetics (5) 5
risk (5) 5
statins (5) 5
adolescent (4) 4
aged (4) 4
apolipoprotein-b (4) 4
cross-sectional studies (4) 4
genetic predisposition to disease (4) 4
hyperlipoproteinemia type ii - drug therapy (4) 4
internal medicine (4) 4
ldl (4) 4
mortality (4) 4
mutations (4) 4
netherlands (4) 4
netherlands - epidemiology (4) 4
prevalence (4) 4
treatment outcome (4) 4
usage (4) 4
young adult (4) 4
abridged index medicus (3) 3
anticholesteremic agents - therapeutic use (3) 3
cardiovascular disease (3) 3
cardiovascular diseases - genetics (3) 3
cardiovascular risk (3) 3
cardiovascular-disease (3) 3
child (3) 3
cholesterol, ldl (3) 3
density-lipoprotein cholesterol (3) 3
density-lipoprotein-receptor (3) 3
dosage and administration (3) 3
familial hypercholesterolaemia (3) 3
health aspects (3) 3
heart-disease (3) 3
hyperlipoproteinemia type ii - complications (3) 3
hyperlipoproteinemia type ii - diagnosis (3) 3
hyperlipoproteinemia type ii - epidemiology (3) 3
individuals (3) 3
lipids (3) 3
low density lipoprotein (3) 3
medical research (3) 3
medicine, experimental (3) 3
pharmacology & pharmacy (3) 3
statin therapy (3) 3
animals (2) 2
anticholesteremic agents (2) 2
anticholesteremic agents - adverse effects (2) 2
b synthesis inhibitor (2) 2
biomarkers - blood (2) 2
cardiovascular diseases - etiology (2) 2
children (2) 2
cholesterol-lowering treatment (2) 2
cohort studies (2) 2
coronary disease - diagnosis (2) 2
coronary disease - genetics (2) 2
coronary disease - therapy (2) 2
coronary-artery-disease (2) 2
coronary-heart-disease (2) 2
cost-effectiveness analysis (2) 2
diabetes (2) 2
dna mutational analysis (2) 2
dose-response relationship, drug (2) 2
epidemiology (2) 2
ester transfer protein (2) 2
general-population (2) 2
genetic screening (2) 2
genetics (2) 2
guidelines (2) 2
hydroxymethylglutaryl-coa reductase inhibitors - administration & dosage (2) 2
hyperlipoproteinemia type ii - therapy (2) 2
intensity (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2015, Volume 385, Issue 9983, pp. 2153 - 2161
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 2016, Volume 68, Issue 3, pp. 252 - 260
Journal Article
Atherosclerosis, ISSN 0021-9150, 2015, Volume 241, Issue 1, pp. 169 - 175
Journal Article
Expert Review of Cardiovascular Therapy, ISSN 1477-9072, 03/2016, Volume 14, Issue 3, pp. 259 - 261
Journal Article
Circulation, ISSN 0009-7322, 11/2016, Volume 134, Issue Suppl_1 Suppl 1, pp. A18756 - A18756
IntroductionCurrent guidelines recommend low-density lipoprotein cholesterol (LDL-C) levels below 1.8 mmol/L and 2.5 mmol/L for heterozygous familial... 
Journal Article
Atherosclerosis, ISSN 0021-9150, 2015, Volume 246, pp. 1 - 6
Journal Article
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2016, Volume 68, Issue 3, pp. 252 - 260
Abstract Background A statin-induced reduction of coronary artery disease (CAD) events and mortality has not been adequately quantified in patients with... 
Cardiovascular | Internal Medicine | intensity | inverse-probability-of-treatment-weighting | lipid lowering | Medical colleges | Hypercholesterolemia | Low density lipoproteins | Mortality | Genetic aspects | Coronary heart disease | Epidemiology | Statins | Cardiovascular agents
Journal Article
Expert review of cardiovascular therapy, 2016, Volume 14, Issue 3, p. 259
Journal Article
Circulation, ISSN 0009-7322, 11/2015, Volume 132, Issue Suppl_3 Suppl 3, pp. A18995 - A18995
IntroductionHeterozygous familial hypercholesterolemia (heFH) is characterized by high levels of low-density lipoprotein cholesterol (LDL-C) and increased risk... 
Journal Article
Circulation, ISSN 0009-7322, 11/2015, Volume 132, Issue Suppl_3 Suppl 3, pp. A12421 - A12421
IntroductionFamilial hypercholesterolemia (FH) is a genetic disorder characterized by severely increased levels of low-density lipoprotein cholesterol (LDL-C)... 
Journal Article
European Heart Journal, ISSN 0195-668X, 02/2017, Volume 38, Issue 8, p. 565
AIMS: Familial hypercholesterolaemia (FH) is an autosomal dominant disease that warrants early diagnosis to prevent premature cardiovascular disease (CVD).... 
Journal Article
JAMA, The Journal of the American Medical Association, ISSN 0098-7484, 03/2015, Volume 313, Issue 10, p. 1029
Journal Article